Prostate cancer is one of the most common cancers among men and is the leading cause of cancer deaths. As a result of effective PSA screening programmes in the West, most patients are diagnosed at an early favorable stage. Unfortunately, such screening programmes are not popular in India. Majority of the patients with prostatic carcinoma present in an advanced stage in our country, when treatment options are limited. Bcl-2, one of the targets for therapy, is an anti-apoptotic mediator that has been found to be involved in the molecular biology of a wide range of human cancers including...